全文获取类型
收费全文 | 1402篇 |
免费 | 49篇 |
国内免费 | 15篇 |
专业分类
耳鼻咽喉 | 5篇 |
儿科学 | 44篇 |
妇产科学 | 15篇 |
基础医学 | 168篇 |
口腔科学 | 26篇 |
临床医学 | 107篇 |
内科学 | 302篇 |
皮肤病学 | 16篇 |
神经病学 | 88篇 |
特种医学 | 38篇 |
外科学 | 77篇 |
综合类 | 54篇 |
预防医学 | 210篇 |
眼科学 | 12篇 |
药学 | 196篇 |
中国医学 | 59篇 |
肿瘤学 | 49篇 |
出版年
2023年 | 37篇 |
2022年 | 58篇 |
2021年 | 73篇 |
2020年 | 58篇 |
2019年 | 84篇 |
2018年 | 91篇 |
2017年 | 40篇 |
2016年 | 27篇 |
2015年 | 25篇 |
2014年 | 105篇 |
2013年 | 78篇 |
2012年 | 68篇 |
2011年 | 99篇 |
2010年 | 79篇 |
2009年 | 69篇 |
2008年 | 47篇 |
2007年 | 76篇 |
2006年 | 32篇 |
2005年 | 38篇 |
2004年 | 27篇 |
2003年 | 18篇 |
2002年 | 12篇 |
2001年 | 9篇 |
2000年 | 14篇 |
1999年 | 8篇 |
1998年 | 8篇 |
1997年 | 8篇 |
1996年 | 2篇 |
1995年 | 3篇 |
1994年 | 2篇 |
1993年 | 3篇 |
1992年 | 4篇 |
1991年 | 6篇 |
1990年 | 2篇 |
1989年 | 5篇 |
1987年 | 2篇 |
1986年 | 1篇 |
1985年 | 27篇 |
1984年 | 27篇 |
1983年 | 17篇 |
1982年 | 16篇 |
1981年 | 9篇 |
1980年 | 12篇 |
1979年 | 6篇 |
1978年 | 5篇 |
1977年 | 11篇 |
1976年 | 2篇 |
1975年 | 1篇 |
1974年 | 7篇 |
1973年 | 6篇 |
排序方式: 共有1466条查询结果,搜索用时 31 毫秒
991.
992.
993.
《Clinical gastroenterology and hepatology》2022,20(7):1488-1498.e11
- Download : Download high-res image (612KB)
- Download : Download full-size image
994.
《Allergology international》2020,69(4):601-609
BackgroundWe examined the feasibility, efficacy and safety of slow low-dose oral immunotherapy (SLOIT) for egg, milk, wheat allergies, with accepted severity-stratified initial and maintenance doses.MethodsChildren with food allergies defined by low-dose oral food challenges (LD-OFCs) to hen's egg (cumulative protein dose up to 983 mg, n = 133), cow's milk (287 mg, n = 50), and wheat (226 mg, n = 45) were recruited. Participants were divided into two groups [SLOIT and control (complete avoidance]) based on their preferences. Participants who selected SLOIT were instructed to take the safe dose daily, with monthly increases, aiming to increase the dose by 10 times in one year. The primary outcome was the proportion of participants who passed the LD-OFCs following 1 year of therapy.ResultsThe participants in SLOIT group ingested their antigen 92.9% of the therapy's day on average. The proportion of participants who passed LD-OFCs was 35.9% (61/170) in the SLOIT group and 8.7% (4/46) in the control group (P < .001); no large differences were observed among allergens. Among the subjects who failed LD-OFCs, the median change in the total dose in the LD-OFC was 235% (interquartile range: 100%–512%) in the SLOIT group and 100% (42%–235%) in the control group (P < .001). Provoked allergic symptoms were observed in only 0.58% (280/48,486) per programmed intake and approximately 50% of the SLOIT group did not experience any obvious allergic symptoms throughout therapy.ConclusionsSLOIT showed significant feasibility, efficacy and safety, providing a promising option to manage patients with severe food allergies. 相似文献
995.
996.
997.
James M. Mathew Mohammed Javeed Ansari Lorenzo Gallon Joseph R. Leventhal 《Human immunology》2018,79(5):322-333
Development of tolerance protocols requires assays or biomarkers that distinguish tolerant recipients from non-tolerant ones to be established. In addition, a thorough understanding of the plausible mechanisms associated with clinical transplant tolerance is necessary to take the field forward. Unlike the majority of molecular signature analyses utilized by others, the emphasis of this article is on the cellular and functional biomarkers of induced transplant tolerance. Immunity to an organ transplant is very complex, comprised of two broad categories – innate and acquired or adaptive immune responses. Innate immunity can be avoided by eliminating or preventing ischemic injuries to the donor organ and tolerance at the level of adaptive immunity can be induced by infusions of a number of cellular products. Since adaptive immune response consists of inflammatory hypersensitivity, cellular (cytotoxic and helper) and humoral aspects, all these need to be measured, and the recipients who demonstrate donor-specific unresponsiveness in all can be considered tolerant or candidates for immunosuppression minimization and/or withdrawal. The mechanisms by which these agents bring about transplant tolerance include regulation, anergy, exhaustion, senescence and deletion of the recipient immune cells. Another proven mechanism of tolerance is full or mixed donor chimerism. However, it should be cautioned that non-deletional tolerance can be reversed. 相似文献
998.
Rena Yadlapati John E. Pandolfino Mark R. Fox Albert J. Bredenoord Peter J. Kahrilas 《Neurogastroenterology and motility》2021,33(1)
Since publication of Chicago Classification version 3.0 in 2015, the clinical and research applications of high‐resolution manometry (HRM) have expanded. In order to update the Chicago Classification, an International HRM Working Group consisting of 52 diverse experts worked for two years and utilized formally validated methodologies. Compared with the prior iteration, there are four key modifications in Chicago Classification version 4.0 (CCv4.0). First, further manometric and non‐manometric evaluation is required to arrive at a conclusive, actionable diagnosis of esophagogastric junction (EGJ) outflow obstruction (EGJOO). Second, EGJOO, distal esophageal spasm, and hypercontractile esophagus are three manometric patterns that must be accompanied by obstructive esophageal symptoms of dysphagia and/or non‐cardiac chest pain to be considered clinically relevant. Third, the standardized manometric protocol should ideally include supine and upright positions as well as additional manometric maneuvers such as the multiple rapid swallows and rapid drink challenge. Solid test swallows, postprandial testing, and pharmacologic provocation can also be considered for particular conditions. Finally, the definition of ineffective esophageal motility is more stringent and now encompasses fragmented peristalsis. Hence, CCv4.0 no longer distinguishes between major versus minor motility disorders but simply separates disorders of EGJ outflow from disorders of peristalsis. 相似文献
999.
Sarah Kim Robert J. Rushakoff Mary Sullivan Heidemarie Windham 《Journal of diabetes science and technology》2012,6(6):1413-1419
Background
Diabetes patients in the intensive care unit (ICU) and either nil per os, on enteral feedings, or on total parenteral nutrition are often treated with sliding-scale insulin (despite lack of evidence showing benefit) or intravenous insulin (IVI) infusion, a nursing intensive procedure requiring hourly glucose measurements, and insulin rate adjustments. We introduced a subcutaneous insulin algorithm (SQIA) that would equal the glucose goals for IVI but have the simplicity of q4 hour adjustable sliding-scale insulin.Methods
As part of a quality improvement project, we developed a simple SQIA that titrates insulin to the requirements of the individual patient. Glucoses were monitored q4 h and SQ rapid-acting insulin administered based on both the previous insulin dose and current glucose level. Fourteen consecutive hyperglycemic patients admitted to ICU-A were placed on the SQIA. Glucose and insulin data were also obtained on 18 patients in an identical ICU-B who were treated with the usual IVI protocol, which is q1–2 h.Results
Duration on the SQIA was 4.5 ± 0.6 days (range 0.8–7) and on IVI 1.9 ± 0.6 days (range 0.25–9). Due to difference in length on protocols, only data for the first 3 days could be statistically compared. During this time, the mean ± standard error of glucoses for the SQ and IV groups were 157.3 ± 3.8 and 157.0 ± 2.2 (not significant). No differences were seen in hypoglycemia rates.Conclusions
A simple SQIA allows insulin doses to be adjusted to the individual patient’s needs and meet current ICU goals for glycemic control. Its adoption may reduce the workload of nurses. 相似文献1000.
Ulrich Geisen Barbara Zieger Lea Nakamura Andreas Weis Jürgen Heinz Jan Jacques Michiels Claudia Heilmann 《Thrombosis research》2014